Skip to main content
. 2025 Oct 15;15:1604554. doi: 10.3389/fcimb.2025.1604554

Figure 1.

Diagram illustrating the effect of *P. gingivalis* on HCT116 cells. Panel (a) shows the treatment process leading to large-EVs purification for miRNA and proteome analysis. Panel (b) details the centrifugation protocol for obtaining large-EVs from cell culture supernatants. Panel (c) includes graphs comparing particle size distributions of control and treated samples, with means of 138.7 nm and 140.2 nm, respectively. Panel (d) contains electron microscopy images showing structural differences between control and treated IEVs. Panel (e) displays fluorescent staining of cells, highlighting WGA, *P. gingivalis*, DAPI, and a merged view.

Purification of lEVs from P. gingivalis-infected HCT116 cells. (a) Schematic showing the generation and mass spectrometry identification of large extracellular vesicles (lEVs) from P. gingivalis–infected HCT116 cells. P. gingivalis at a multiplicity of infection (MOI) of 100 was used for treatment. (b) Centrifugation protocol and workflow for lEV enrichment from P. gingivalis–infected HCT116 cells. (c) Representative particle size distribution of lEVs from P. gingivalis–infected or uninfected HCT116 cells determined by nanoparticle tracking analysis. Three biological replicates were analyzed for each group. (d) Transmission electron microscopy (TEM) image of lEVs isolated from P. gingivalis–infected or uninfected HCT116 cells. Scale bar = 100 nm. (e) Visualization of P. gingivalis infection in HCT116 cells. Bacteria were pre-stained with eFluor™ 670 (red), followed by infection of HCT116 cells. After 12 h, cell membranes were labeled with wheat germ agglutinin (WGA; green), and nuclei were counterstained with DAPI (blue).